Skip to Content
Morningstar

Calamos International Growth C CIGCX

Morningstar Medalist Rating
Medalist Rating as of | See Calamos Investment Hub
  • NAV / 1-Day Return 13.69  /  0.94 %
  • Total Assets 193.2 Mil
  • Adj. Expense Ratio
    1.950%
  • Expense Ratio 1.950%
  • Distribution Fee Level Average
  • Share Class Type Level Load
  • Category Foreign Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield —
  • Turnover 129%

USD | NAV as of Oct 02, 2023 | 1-Day Return as of Oct 02, 2023, 10:12 PM GMT+0

Morningstar’s Analysis CIGCX

Will CIGCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Process Pillar

The Process Pillar is our assessment of how sensible, clearly defined, and repeatable CIGCX’s performance objective and investment process is for both security selection and portfolio construction.

People Pillar

The People Pillar is our evaluation of the CIGCX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

Parent Pillar

The Parent Pillar is our rating of CIGCX’s parent organization’s priorities and whether they’re in line with investors’ interests.

Calamos International Growth C boasts strong Process and People Pillar ratings, but other weaknesses hold this strategy's Morningstar Medalist Rating at Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings CIGCX

More CIGCX Holdings
  • Current Portfolio Date
  • Equity Holdings 84
  • Bond Holdings 0
  • Other Holdings 4
  • % Assets in Top 10 Holdings 26.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

4.64
9,919,912
Healthcare

ASML Holding NV

3.64
7,789,423
Technology

Keyence Corp

2.73
5,833,645
Technology

Advantest Corp

2.63
5,629,211
Technology

Taiwan Semiconductor Manufacturing Co Ltd

2.46
5,254,761
Technology

AIA Group Ltd

2.25
4,814,279
Financial Services

AstraZeneca PLC

2.11
4,515,743
Healthcare

LVMH Moet Hennessy Louis Vuitton SE

2.07
4,420,933
Consumer Cyclical

Rolls-Royce Holdings PLC

1.98
4,240,067
Industrials

Sony Group Corp

1.95
4,177,514
Technology